Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preincisional versus postincisional ultrasound-guided TAP block for chronic postsurgical pain after open inguinal hernia repair
2024-513582-39-01Phase 4Authorised
- Sponsor
- Hospital Central de la Defensa Gómez Ulla
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levobupivacaine in Persistent postsurgical pain (PPSP) (2 arms), sponsored by Hospital Central de la Defensa Gómez Ulla. Primary endpoint: Prevention of chronic postsurgical pain. Planned start Aug 2024; status: authorised.
02
Drugs
levobupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on 2024-513582-39-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513582-39-01.